During the inaugural meeting held earlier this year in San Francisco, Calif., at Amazon Web Services, the board appointed the following executive officers: John Baldoni, former senior vice president at GSK, was elected chairman; Brandon Allgood, co-founder and chief technology officer of Numerate, was elected vice chairman; Angeli Moeller, co-lead of AI and head of IT Business Partnering Research at Bayer, was elected treasurer; and Naheed Kurji, president and CEO of Cyclica Inc., was elected secretary.
“In selecting industry experts from established and emerging companies to lead AAIH, the board has demonstrated its commitment to the integration of AI across the full spectrum of healthcare with the goal of improving patients’ lives by creating more efficient, sustainable and accessible biomedical research and healthcare systems,” said Annastasiah Mudiwa Mhaka of Adjuvant Partners, who will be serving as president of the organization.
In addition to naming executive officers, the AAIH Board identified six standing committees that will oversee AAIH’s work in promoting advancement of AI. They are Education and Accreditation; Federal Engagement and Regulatory Affairs; Investment and Commercialization; Communications; Technology and Standards Development; and Industry Performance and Data Analytics.
Over the next several months the AAIH Board and its committees will begin developing strategy and initiatives aimed at educating the public about the benefits and risks of AI, promoting investment in AI-related research and development, and working with government officials in the United States, European Union and other jurisdictions to develop regulatory and technology standards.
“In recent years AI companies have begun implementing increasingly sophisticated machine learning techniques to significantly mitigate and, in some cases, eliminate inefficiencies in the current healthcare system,” Kurji added. “These innovations have accelerated growth of AI in the healthcare industry, and engendered enthusiasm and hope in consumers and patients alike. AAIH will work to collaboratively help bring these new health care advances to patients world-wide.”
AAIH’s founding companies and organizations include Amazon Web Services (AWS), Bayer, Beyond Limits, BlackThorn Therapeutics, The Buck Institute for Research on Aging, Cyclica, Envisagenics, GE Healthcare, Genialis, GSK, Insilico Medicine, Johnson & Johnson, minds.ai, Netrias, NuMedii, Numerate, Nuritas, Owkin, Progenics Pharmaceuticals, Recursion, SimplicityBio, and the University of Pittsburgh.
The AAIH is a multi-stakeholder 501(c)(4) non-profit advocacy and education organization dedicated to promoting the further development and implementation of AI in healthcare. The membership-based alliance is a coalition of technology developers, pharmaceutical and device companies, research organizations and other associations engaged in advancing AI in the healthcare industry.